dove comprare il cialis acquisto viagra online italia sildenafil prezzo acheter du cialis en pharmacie acheter du levitra viagra generique pharmacie cialis indien comprar levitra generica cialis costo tadalafil 20mg preis

Tag Archive | "survival"

Chemoradiation offered better survival than accelerated radiation in head and neck squamous cell carcinomas

Wednesday, March 19, 2014

0 Comments

Source: www.oncologypractice.com Author: Neil Osterweil, Oncology Report Digital Network Concurrent chemoradiation offered better overall survival and disease-free survival than accelerated radiotherapy in patients with moderately advanced squamous cell carcinomas of the head and neck, investigators reported at the Multidisciplinary Head and Neck Symposium. Actuarial rates of 2-year overall survival and disease-free survival in patients treated […]

Continue reading...

Study: Oropharyngeal cancer on the rise in young adults

Friday, January 31, 2014

0 Comments

Source: www.sciencecodex.com Author: staff A new study reveals an alarming increase in oropharyngeal cancers among young adults. While the exact cause for this phenomenon is unknown, the human papillomavirus (HPV) may be to blame. According to researchers from Henry Ford Hospital in Detroit there was an overall 60 percent increase from 1973 and 2009 in […]

Continue reading...

Certain genetic alterations may explain head and neck cancer survival disparities

Monday, December 9, 2013

0 Comments

Source: www.sciencecodex.com Author: staff Certain genetic alterations to the PAX gene family may be responsible for survival disparities seen between African-American and non-Latino white men with head and neck cancer, according to results presented here at the Sixth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held […]

Continue reading...

Study reveals genetic diversity within tumors predicts outcome in head and neck cancer

Saturday, May 25, 2013

0 Comments

Source: bionews-tx.com Researchers at the Massachusetts General Hospital (MGH) and Massachusetts Eye and Ear Infirmary have developed a new way to predict the survival rate of patients who have squamous cell carcinoma of the head and neck, thanks to a study partially funded by a CPRIT grant. One of the problems with treating cancer is […]

Continue reading...

Study examines role of DNA, HPV in oral cancer survival

Tuesday, May 14, 2013

0 Comments

Source: www.drbicuspid.com Author: DrBicuspid Staff High-risk types of human papillomavirus (HPV) are increasingly associated with oropharyngeal squamous cell carcinoma (OPSCC). However, HPV-positive OPSCC is highly curable, and patients with HPV have better survival compared with HPV-negative patients, whose cancers are usually associated with alcohol and tobacco use. To better understand the molecular mechanisms underlying these […]

Continue reading...

HPV-positive African-Americans with throat cancer have better outcomes

Monday, April 1, 2013

0 Comments

Source: www.drbicuspid.com Author: DrBicuspid Staff African-Americans with throat cancer who are positive for the human papillomavirus (HPV) have better outcomes than African-Americans without HPV, according to a new study in Clinical Cancer Research (March 26, 2013). African-Americans who are HPV-negative also fared worse than Caucasians both with and without HPV present in oropharyngeal cancer, concluded […]

Continue reading...

The effect of treating institution on outcomes in head and neck cancer

Wednesday, December 12, 2012

0 Comments

Source: medicalxpress.com Patients with head and neck cancer receiving radiation treatment at an academic center have a higher survival rate than those receiving treatment at a community center, according to a study in the December 2012 issue of Otolaryngology–Head and Neck Surgery. “Despite similar rates of treatment completion and rate of treatment breaks between groups, […]

Continue reading...

Interim results from CEL-SCI’s Multikine Phase III study on head and neck cancer

Tuesday, October 23, 2012

0 Comments

Source: www.news-medical.net CEL-SCI Corporation announced today that an interim review of the safety data from its open label, randomized, controlled, pivotal Phase III study of Multikine (Leukocyte Interleukin, Injection) investigational immunotherapy by an Independent Data Monitoring Committee (IDMC) raised no safety concerns. The IDMC also indicated that no safety signals were found that would call […]

Continue reading...

Taiwan reports highest oral cancer survivor rate

Wednesday, March 7, 2012

0 Comments

Source: www.chinapost.com.tw/ Taiwan has reported the highest five-year survival rate for patients with oral cancer in the world, a hospital official said yesterday. On average, more than 70 percent of the oral cancer patients treated at National Taiwan University Hospital (NTUH) live for more than five years after being diagnosed, said Ko Jeng-yuh, head of […]

Continue reading...

UT MD Anderson article offers one roadmap for defining value in health care, earns national award from leading journal

Friday, February 3, 2012

0 Comments

Source: http://www.newswise.com Author: University of Texas M. D. Anderson Cancer Center A team from The University of Texas MD Anderson Cancer Center is receiving a national award for a research article tackling a question vital to the future of health care with reform regulations looming, competition growing and costs rising. The MD Anderson study took […]

Continue reading...